Armistice Capital, LLC 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 681 9.990% |
381 (+126.96%) |
Filing |
| 2021-06-30 06:16 am Unchanged |
2021-06-29 | 13G | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 300 9.990% |
0 (Unchanged) |
Filing |
| 2021-06-30 06:10 am Sale |
2021-06-28 | 13D | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 300 9.990% |
-2,191 (-87.96%) |
Filing |
| 2021-06-25 4:21 pm Purchase |
2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 2,491 49.800% |
2,491 (New Position) |
Filing |